NeuPath Health Past Earnings Performance
Past criteria checks 0/6
NeuPath Health has been growing earnings at an average annual rate of 37.1%, while the Healthcare industry saw earnings growing at 16.7% annually. Revenues have been growing at an average rate of 5.9% per year.
Key information
37.1%
Earnings growth rate
62.8%
EPS growth rate
| Healthcare Industry Growth | -6.7% |
| Revenue growth rate | 5.9% |
| Return on equity | 0.03% |
| Net Margin | -0.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Investors Don't See Light At End Of NeuPath Health Inc.'s (CVE:NPTH) Tunnel
Aug 18
These 4 Measures Indicate That NeuPath Health (CVE:NPTH) Is Using Debt Extensively
Jun 16The Market Doesn't Like What It Sees From NeuPath Health Inc.'s (CVE:NPTH) Revenues Yet
Apr 23Does NeuPath Health (CVE:NPTH) Have A Healthy Balance Sheet?
Mar 01Revenues Not Telling The Story For NeuPath Health Inc. (CVE:NPTH) After Shares Rise 27%
Dec 20Little Excitement Around NeuPath Health Inc.'s (CVE:NPTH) Revenues
Aug 19Revenue & Expenses Breakdown
How NeuPath Health makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 69 | 0 | 10 | 0 |
| 31 Mar 24 | 68 | 0 | 9 | 0 |
| 31 Dec 23 | 66 | 0 | 9 | 0 |
| 30 Sep 23 | 65 | -2 | 9 | 0 |
| 30 Jun 23 | 65 | -3 | 9 | 0 |
| 31 Mar 23 | 63 | -3 | 9 | 0 |
| 31 Dec 22 | 63 | -4 | 9 | 0 |
| 30 Sep 22 | 62 | -3 | 10 | 0 |
| 30 Jun 22 | 62 | -3 | 10 | 0 |
| 31 Mar 22 | 62 | -3 | 10 | 0 |
| 31 Dec 21 | 61 | -3 | 10 | 0 |
| 30 Sep 21 | 58 | -3 | 10 | 0 |
| 30 Jun 21 | 55 | -3 | 9 | 0 |
| 31 Mar 21 | 50 | -5 | 9 | 0 |
| 31 Dec 20 | 48 | -5 | 8 | 0 |
| 30 Sep 20 | 48 | -7 | 8 | 0 |
| 30 Jun 20 | 49 | -8 | 8 | 0 |
| 31 Mar 20 | 50 | -5 | 8 | 0 |
| 31 Dec 19 | 50 | -5 | 8 | 0 |
| 31 Dec 18 | 40 | -5 | 8 | 0 |
| 31 Dec 17 | 20 | -4 | 6 | 0 |
Quality Earnings: NPTH is currently unprofitable.
Growing Profit Margin: NPTH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NPTH is unprofitable, but has reduced losses over the past 5 years at a rate of 37.1% per year.
Accelerating Growth: Unable to compare NPTH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NPTH is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: NPTH has a negative Return on Equity (0.027%), as it is currently unprofitable.